|
已选(0)清除
条数/页： 排序方式： |
| Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes 期刊论文
CANCER BIOLOGY & MEDICINE, 2020, 卷号: 17
-
  收藏 | 浏览/下载：37/0 | 提交时间：2020/10/26
GENOME-WIDE ASSOCIATION SQUAMOUS-CELL CARCINOMA Cervical esophageal cancer survival esophagectomy radiochemotherapy |
| Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study 期刊论文
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 卷号: 25
作者: Wang Xueqian; Zhang Ying; Hou Wei; Wang Yingtian; Zheng Jiabin; Li Jie; Lin Lizhu; Jiang Yilan; Wang Shenyu; Xie Ying; Zhang Hongliang; Shu Qijin; Li Ping; Wang Wei ; You Jianliang; Li Ge; Liu Jie; Fan Huiting; Zhang Meiying; Lin Hongsheng
收藏 | 浏览/下载：25/0 | 提交时间：2020/10/26
CELL LUNG-CANCER ADJUVANT CHEMOTHERAPY Chinese medicine non-small cell lung cancer postoperative care cohort study disease-free survival |
| ABO blood group is a predictor of survival in patients with laryngeal cancer 期刊论文
CHINESE JOURNAL OF CANCER, 2016, 卷号: 35
-
收藏 | 浏览/下载：24/0 | 提交时间：2020/10/26
GENOME-WIDE ASSOCIATION SQUAMOUS-CELL CARCINOMA PANCREATIC-CANCER NASOPHARYNGEAL CARCINOMA COHORT CONSORTIUM CHINESE PATIENTS GROUP ALLELES RISK POPULATION EXPRESSION The ABO blood group Laryngeal cancer Prognosis Survival |
| A new prognostic histopathologic classification of nasopharyngeal carcinoma 期刊论文
CHINESE JOURNAL OF CANCER, 2016, 卷号: 35
-
收藏 | 浏览/下载：26/0 | 提交时间：2020/10/26
CONCURRENT CISPLATIN-RADIOTHERAPY ADJUVANT CHEMOTHERAPY RANDOMIZED-TRIAL STAGING SYSTEM CANCER CHEMORADIOTHERAPY METAANALYSIS CHINA SURVIVAL UNION Nasopharyngeal carcinoma Pathologic classification Prognosis |
| The response of Golgi protein 73 to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma may relate to the influence of certain chemotherapeutics 期刊论文
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 卷号: 14
-
收藏 | 浏览/下载：27/0 | 提交时间：2020/10/26
SERUM MARKER SURVIVAL EXPRESSION GOLPH2 GP73 hepatocellular carcinoma transcatheter arterial chemoembolization Golgi protein 73 chemotherapeutics |
| Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population 期刊论文
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2013, 卷号: 14
-
收藏 | 浏览/下载：25/0 | 提交时间：2020/10/26
COLORECTAL-CANCER GENE POLYMORPHISMS CLINICAL-RESPONSE PLUS CARBOPLATIN REPAIR GENES SURVIVAL ERCC1 ASSOCIATION PLATINUM FOLATE Non-small cell lung cancer Single nucleotide polymorphism Methylenetetrahydrofolate reductase Gemcitabine Excision repair cross-complementation group 1 |
